About Aviana

Meet Our Board of Directors

Discover the Minds Guiding Aviana Molecular's Strategic Direction: Explore the Profound Expertise and Vision of Our Distinguished Board Members.

Vanaja Ragavan, M.D.

Founder, President and CEO

Dr. Ragavan, a board-certified endocrinologist with 20+ years in the pharmaceutical industry, excels in leadership and innovation. Former Medical Officer at the FDA and seasoned professional in multinational pharmaceutical firms, she transitioned to entrepreneurship as a founder and angel investor. Uniquely qualified, she has led teams in drug development, devices, and diagnostics globally. Founder of Aviana Molecular Technologies in 2008, she focuses on unmet clinical needs in infection diagnosis. Based at the Lankenau Institute for Medical Research, her dynamic team has advanced groundbreaking products. A graduate of Harvard (A.B.) and NYU Medical School (M.D.), Dr. Ragavan shapes the future of healthcare.

Gary Foster, M.D.

Chairman of the Board

Gary Foster, MD obtained his B.S. in Zoology at Brigham Young University and his M.D. degree at the University of Utah. He completed his ophthalmology residency at the Moran Eye Center and currently serves as the medical director for the Laser Eye Center of Northern Colorado. He is on the Cataract Committee, chairs the Challenging and Complex Cataract Committee, and co-chairs the Clinical Classroom Committee for the American Society of Cataract and Refractive Surgery. He has served as a Chair for the Investment Committee and currently is the chair of the Ophthalmology section for Strathspey Crown Holdings. He chairs the board of managers for MyCore, LLC and co-chairs the scientific advisory board for Aviana.

Tony Sine

Board Member

Anthony Sine brings more than 20 years of corporate governance, financial strategy, international business, product development and general counsel experience to Aviana’s Board of Directors. He has worked with companies across all life stages, from ideation to Fortune 500, and across a broad swath of strategic transactions that range from mergers and acquisitions, debt financings, venture capital, private and public market equity, to joint development and strategic collaborations. Sine currently serves as CEO of Legrande Corporation, a technology platform empowering doctors to optimize patient health through personalization. He holds a J.D. from Georgetown Law and a B.A. in Philosophy from Brigham Young University.

Meet Our Executive Leadership

Get to Know the Visionaries Steering Aviana Molecular: Explore Our Esteemed Executive Team Leading the Charge in Healthcare Innovation.

Mark Cosgrove

VP Finance & CFO

With a career rooted in corporate banking at Southeast Bank in Miami, Mark Cosgrove has been a pivotal figure in the finance sector. From overseeing Fortune 100 companies to leading a commercial portfolio of middle market firms, his expertise spans asset-based lending, leverage buy-outs, and technology. As the founder of Cosgrove & Company, an esteemed investment banking firm, he has guided over 120 client engagements in capital raising, mergers & acquisitions, strategic partnerships, and more. With a focus on Life Science, environmental services, and technology, Mr. Cosgrove excels in advising both mature and early-stage businesses, showcasing his profound industry insight and strategic prowess.

Peter Beaumont

DVM: Scientific Advisor

Bringing over 40 years of experience in veterinary medicine and the animal health industry, Dr. Peter Beaumont is a distinguished figure. Currently serving as Chairman of Trupanion’s Veterinary Advisory Board and Independent Third-Party Veterinarians, he has been a stalwart on its main board until 2015. As a practice owner, angel investor, and consultant, he has lent his expertise to various organizations in the UK and USA, including Veterinary Business Development Ltd., Novartis Inc., and more. With a veterinary degree from the University of Edinburgh, internship/residency at UPenn, CVPM from Purdue, and an MBA from NYU Stern, Dr. Beaumont is a respected authority in both clinical and business aspects of the industry.

Our History

Redefining Healthcare Solutions

Tracing the Journey of Aviana Molecular:
Explore Our Evolution, Milestones, and Commitment to Healthcare Advancements.

At Aviana Molecular, our history is a testament to relentless innovation and a passion for transforming healthcare diagnostics. From our founding principles to our groundbreaking achievements, each milestone underscores our dedication to pioneering technologies that redefine patient care, shaping a legacy built on innovation, excellence, and a steadfast commitment to improving lives.